Name: MURAL ONCOLOGY PLC (MURA) Stock
Brand: MURAL ONCOLOGY PLC
Rating: 3 (3 reviews)

MURA Latest News, Press Relases and Analysis

All

Press Releases

9 days ago - By: Mural Oncology plc - Mentions: XOMA

Mural Oncology Announces that Mural Shareholders Approve the Proposed Acquisition by XRA 5 Corp., a Wholly Owned Subsidiary of XOMA Royalty

9 days ago - By: Mural Oncology plc

Mural Oncology Announces that Mural Shareholders Approve the Proposed Acquisition by XRA 5 Corp., a Wholly Owned Subsidiary of XOMA Royalty

a month ago - By: Halper Sadeh LLC - Mentions: PHLT ARIS

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PHLT, ARIS, MURA on Behalf of Shareholders

2 months ago - By: Stocktwits - Mentions: XOMA

Mural Oncology To Be Acquired By Xoma Royalty

3 months ago - By: The Motley Fool

Mural Oncology (MURA) Q2 Loss Widens 49%

6 months ago - By: Mural Oncology plc

FORM 8.1(a) & (b) - Mural Oncology plc

a month ago - By: Mural Oncology plc

Mural Oncology Announces Commencement of Mailing of Definitive Proxy Statement and Details of Scheme Meeting and Extraordinary General Meeting

a month ago - By: Mural Oncology plc

Mural Oncology Announces Commencement of Mailing of Definitive Proxy Statement and Details of Scheme Meeting and Extraordinary General Meeting

a month ago - By: Halper Sadeh LLC - Mentions: ARIS MTSR GTLS

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ARIS, MTSR, GTLS, MURA on Behalf of Shareholders

7 months ago - By: Stocktwits

Mural Oncology's Retail Buzz Explodes After Micro-Cap Biotech Mulls Strategic Alternatives

7 months ago - By: Benzinga - Mentions: CRMD CNSP DATS TNON ...

Nasdaq Gains 50 Points; US New Home Sales Rise In February

2 months ago - By: Halper Sadeh LLC - Mentions: NWE GES TZUP

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates NWE, GES, MURA, TZUP on Behalf of Shareholders

2 months ago - By: Halper Sadeh LLC

MURA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Mural Oncology plc Is Fair to Shareholders

7 months ago - By: Benzinga - Mentions: CNSP CNM DATS MULN ...

US Stocks Mixed; Core & Main Posts Downbeat Earnings

2 months ago - By: Mural Oncology plc

Mural Oncology Announces Entry into Agreement to be Acquired by XRA 5 Corp., a wholly owned subsidiary of XOMA Royalty for between $2.035 and $2.24 in Cash per Share

3 months ago - By: Mural Oncology plc

Mural Oncology Announces Second Quarter Financial Results and Provides Business Update

3 months ago - By: Mural Oncology plc

Mural Oncology Announces Second Quarter Financial Results and Provides Business Update

6 months ago - By: Mural Oncology plc

Mural Oncology Announces Number of Relevant Securities in Issue

7 months ago - By: Mural Oncology, Inc.

MURAL ONCOLOGY PLC (MURA) Stock News

MURA Latest News, Press Relases and Analysis

Mural Oncology Announces that Mural Shareholders Approve the Proposed Acquisition by XRA 5 Corp., a Wholly Owned Subsidiary of XOMA Royalty

Mural Oncology Announces that Mural Shareholders Approve the Proposed Acquisition by XRA 5 Corp., a Wholly Owned Subsidiary of XOMA Royalty

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PHLT, ARIS, MURA on Behalf of Shareholders

Mural Oncology To Be Acquired By Xoma Royalty

Mural Oncology (MURA) Q2 Loss Widens 49%

FORM 8.1(a) & (b) - Mural Oncology plc

Mural Oncology Announces Commencement of Mailing of Definitive Proxy Statement and Details of Scheme Meeting and Extraordinary General Meeting

Mural Oncology Announces Commencement of Mailing of Definitive Proxy Statement and Details of Scheme Meeting and Extraordinary General Meeting

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ARIS, MTSR, GTLS, MURA on Behalf of Shareholders

Mural Oncology's Retail Buzz Explodes After Micro-Cap Biotech Mulls Strategic Alternatives

Nasdaq Gains 50 Points; US New Home Sales Rise In February

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates NWE, GES, MURA, TZUP on Behalf of Shareholders

MURA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Mural Oncology plc Is Fair to Shareholders

US Stocks Mixed; Core & Main Posts Downbeat Earnings

Mural Oncology Announces Entry into Agreement to be Acquired by XRA 5 Corp., a wholly owned subsidiary of XOMA Royalty for between $2.035 and $2.24 in Cash per Share

Mural Oncology Announces Second Quarter Financial Results and Provides Business Update

Mural Oncology Announces Second Quarter Financial Results and Provides Business Update

Mural Oncology Announces Number of Relevant Securities in Issue

Mural Oncology Announces Plans to Explore Strategic Alternatives